Ending an epidemic: innovations to eradicate HIV

EU Confidential

POLITICO

Politics, News Commentary, News

4.4 • 175 Ratings

🗓️ 18 July 2023

⏱️ 22 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Governments around the world have committed to end HIV by 2030. The target is known as the 95-95-95 goals — 95 percent of people living with HIV diagnosed and knowing their status, 95 percent of those linked to HIV treatment and care and 95 percent of those on treatment to be undetectable, therefore unable to pass the virus on. Innovative medications have already changed HIV infection from a deadly disease to a manageable chronic condition. But to end HIV entirely, we will need to invest in innovation, develop new treatment and prevention options focusing on the needs of individuals and their preferences, new healthcare policies and new approaches to fight the stigma that HIV still carries. Host David Baker speaks to Jared Baeten, Gilead Sciences’ HIV Clinical Development Vice President; Cristina Mussini, professor of infectious diseases at the University of Modena and Reggio Emilia, Italy; Maria José Fuster, professor of psychology at Spain’s National University of Distance Education in Madrid and who has been living with HIV for 34 years; and Susana Solís Pérez, a member of the European Parliament from the Renew Europe group, to find out the practical steps that Europe needs to take to end the HIV epidemic for everyone, everywhere by the end of the decade. Hosted on Acast. See acast.com/privacy for more information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	This special podcast episode is sponsored by Gilead Sciences and produced by Politico Studio.
0:09.4	Ask any veteran of the fight against AIDS and HIV when they first felt the world was gaining
0:15.9	ground against what had become a devastating epidemic, and they will say 1996. When we see each other again in the not-to-distant future,
0:24.6	we can truly say that Vancouver 96 was a catalyst for change.
0:29.6	Julio Montana, the 9th International AIDS Conference,
0:34.6	heralded the arrival of a new era for HIV treatment.
0:40.6	And to be perfectly honest with you, we did not even begin to comprehend the magnitude of this breakthrough.
0:48.5	A new combination of three anti-retroviral drugs were at last proving effective against the virus.
0:56.2	After Vancouver 96, death rates for AIDS in the world, anywhere where the treatment was
1:02.9	applied, dropped by about 90%.
1:05.9	Up to that point, living with HIV almost always meant an early death.
1:10.8	I had many opportunistic infections, and I had to fight very hard to recover my health.
1:18.3	And during these years, I lost many, many loved ones.
1:23.6	Suddenly there was real hope for people living with the virus, like artist Tico Kerr.
1:29.0	I immediately got on the new protease inhibitors,
1:31.9	and it totally changed my life.
1:34.7	It brought me back immediately.
1:36.2	Triple therapy, as the drugs became known,
1:38.7	changed HIV infection from a life-threatening disease
1:42.1	to a manageable chronic condition.
1:45.0	And now the descendants of those three innovative drugs
1:48.2	are at the forefront of the world's efforts to eliminate HIV entirely.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from POLITICO, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of POLITICO and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.